Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study
Top Cited Papers
- 1 April 2004
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 363 (9417), 1253-1263
- https://doi.org/10.1016/s0140-6736(04)15997-7
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patientsAIDS, 2003
- Potency of Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs) Used in Combination with Other Human Immunodeficiency Virus NNRTIs, NRTIs, or Protease InhibitorsAntimicrobial Agents and Chemotherapy, 2002
- SENC (Spanish efavirenz vs. nevirapine comparison) trial: A randomized, open-label study in HIV-infected naive individualsHIV Research & Clinical Practice, 2002
- The Consistency of Adherence to Antiretroviral Therapy Predicts Biologic Outcomes for Human Immunodeficiency Virus–Infected Persons in Clinical TrialsClinical Infectious Diseases, 2002
- Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: Role of hepatitis C and B infectionsHepatology, 2002
- The Steady‐State Pharmacokinetics of Efavirenz and Nevirapine When Used in Combination in Human Immunodeficiency Virus Type 1–Infected PersonsThe Journal of Infectious Diseases, 2001
- Drug–Induced Liver Injury: Mechanisms and Test SystemsHepatology, 2001
- Comparison of twice-daily stavudine plus once- or twice-daily didanosine and nevirapine in early stages of HIV infection: the Scan StudyAIDS, 2000
- Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in AdultsNew England Journal of Medicine, 1999
- Severe Adverse Cutaneous Reactions to DrugsNew England Journal of Medicine, 1994